SCHEMBL4065508

SCHEMBL4065508

Cc1cccc(N2c3ccccc3NS2(=O)=O)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 2/20 0.40
HTR3E A5X5Y0 1/20 0.40
HTR3B O95264 1/20 0.40
HTR3A P46098 1/20 0.40
HTR3D Q70Z44 1/20 0.40
HTR3C Q8WXA8 1/20 0.40
KDM4E B2RXH2 3/20 0.39
ALOX5 P09917 2/20 0.37
ALDH1A1 P00352 3/20 0.35
HPGD P15428 3/20 0.35
HSD17B10 Q99714 2/20 0.35
POLB P06746 1/20 0.35
CASP1 P29466 1/20 0.35
OPRL1 P41146 5/20 0.34
GAA P10253 1/20 0.34
OPRM1 P35372 1/20 0.33
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4943537 0.77 SMN1; SMN2 (0.38) RECQLKDM4EALOX5ALDH1A1HPGD
SCHEMBL4057100 0.75 GRIN2D (0.37) RECQLKDM4EALDH1A1OPRL1OPRM1
SCHEMBL3600126 0.74 MGLL (0.39) RECQLKDM4EALOX5ALDH1A1HPGD
SCHEMBL4057477 0.74 SMN1; SMN2 (0.39) KDM4EALDH1A1OPRL1GAAOPRM1
SCHEMBL4055064 0.72 LMNA (0.39) RECQLKDM4EALDH1A1HPGDOPRL1
SCHEMBL4056735 0.72 POLB (0.41) RECQLHTR3EHTR3BHTR3AHTR3D
SCHEMBL4059648 0.72 SLC6A2 (0.42) ALOX5ALDH1A1HPGDHSD17B10GAA
SCHEMBL4053612 0.72 HCAR1 (0.37) RECQLKDM4EOPRL1OPRM1LMNA
SCHEMBL3596885 0.71 PTPN1 (0.41) RECQLKDM4EOPRL1OPRM1
SCHEMBL4059578 0.70 NPSR1 (0.37) ALDH1A1OPRL1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2061776-A1 ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE Wyeth a Corporation of the State of Delaware (US) 2009-05-27 EP disclosed
US-20080161366-A1 AMINOALKYL SUBSTITUTED ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE WYETH (US) 2008-07-03 US disclosed
WO-2008073459-A1 ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE WYETH (US) 2008-06-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161366-A1 AMINOALKYL SUBSTITUTED ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE SLC6A4, SLC6A2, SLC6A3 RECQL 2585/4885HTR3E 59/4885HTR3B 38/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.